The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman, Monika Bullinger, A. Cull, N. Duez, A. Filiberti, Hans‐Henning Flechtner, Stewart B. Fleishman, J.C.J.M. de Haes, S. Kaasa, M. Klee, David Osoba, Darius Razavi, Peter B. C. Rofe, S Schraub, K.C.A. Sneeuw, Marianne Sullivan, Fumikazu Takeda

JNCI Journal of the National Cancer Institute, 1993

The Netherlands Cancer Institute, Zimmer Biomet (Germany), European Organisation for Research and Treatment of Cancer, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Cologne, Long Island Jewish Medical Center, University of Amsterdam, Academic Medical Center, Norwegian Cancer Society, Rigshospitalet, BC Cancer Agency, Institut Jules Bordet, Royal Adelaide Hospital, Centre Hospitalier Universitaire de Besançon, Sahlgrenska University Hospital, Saitama Cancer Center

Publisher Website

Abstract

This research paper explore the methodology and findings associated with JNCI Journal of the National Cancer Institute. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

15757

Citations

View on Google Scholar

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

Abstract

Journal Details

Join JournalsHub

Welcome Back